Paul Rivard, EVP of Operations, GC at MyMD Pharmaceuticals, Inc. (MYMD), bought 15,000 shares at $6.03 ($90K) on 2021-11-23, disclosed to the SEC on 2021-11-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| MYMD | BUY | 2022-12-08 | $15K | — | Filing → |